IPP Bureau

Supriya Lifesciences received GMP certification from ANVISA Brazil
Supriya Lifesciences received GMP certification from ANVISA Brazil

By IPP Bureau - January 06, 2024

The clearance of this audit marks the successful registration of 8 APIs with CADIFA

Hyderabad to host 66th All India Congress of Obstetrics and Gynaecology 2024
Hyderabad to host 66th All India Congress of Obstetrics and Gynaecology 2024

By IPP Bureau - January 05, 2024

The congress aims at emphasizing on the most recent trends, advancements in the field of Obstetrics & Gynaecology

PayNearby, Star Health join forces to provide health cover to uninsured across Bharat
PayNearby, Star Health join forces to provide health cover to uninsured across Bharat

By IPP Bureau - January 05, 2024

Star Health's convenient claims process, valued added offerings like free telemedicine consultations with expert doctors

Lupin receives tentative approval from USFDA for Dapagliflozin and Saxagliptin tablets
Lupin receives tentative approval from USFDA for Dapagliflozin and Saxagliptin tablets

By IPP Bureau - January 04, 2024

Dapagliflozin and Saxagliptin Tablets (RLD Qtern) had estimated annual sales of US $5 million in the US

CCRAS launches ‘SMART 2.0’ for ayurveda teaching professionals
CCRAS launches ‘SMART 2.0’ for ayurveda teaching professionals

By IPP Bureau - January 04, 2024

Medway Hospitals raises US$5 million in a financing round led by Kyra Ventures
Medway Hospitals raises US$5 million in a financing round led by Kyra Ventures

By IPP Bureau - January 04, 2024

Medway setup a state-of-the-art Heart Institute in Chennai

Mandaviya lays foundation stone for NCDC regional branch, state branches and 2 BSL-3 laboratories
Mandaviya lays foundation stone for NCDC regional branch, state branches and 2 BSL-3 laboratories

By IPP Bureau - January 03, 2024

Dedicates upgraded National Centre for Disease Control, Delhi and a Temporary Regional Branch of NCDC to the nation

India screens 1 crore+ person for Sickle Cell Disease
India screens 1 crore+ person for Sickle Cell Disease

By IPP Bureau - January 03, 2024

The National Sickle Cell Anaemia Elimination Mission was launched on 1st July 2023 at Shahdol, Madhya Pradesh

Alembic Pharmaceuticals received 8 USFDA approvals in Q3FY24
Alembic Pharmaceuticals received 8 USFDA approvals in Q3FY24

By IPP Bureau - January 03, 2024

The company has received five final approvals

Strides Pharma Science to invest in AMP-6, AMP-8
Strides Pharma Science to invest in AMP-6, AMP-8

By IPP Bureau - January 03, 2024

AMP-6 & AMP-8 are special purpose entities formed for purpose of setting up captive solar power projects in Karnataka

Dr. Reddy's acquires MenoLabs
Dr. Reddy's acquires MenoLabs

By IPP Bureau - January 03, 2024

Glenmark to launch biosimilar of anti-diabetic drug Liraglutide in India
Glenmark to launch biosimilar of anti-diabetic drug Liraglutide in India

By IPP Bureau - January 03, 2024

Liraglutide belongs to the class of glucagon like peptide 1 receptor agonist (GLP?1 RA) drugs

Healthcare Triangle completes US$2 million private placement debt offering
Healthcare Triangle completes US$2 million private placement debt offering

By IPP Bureau - January 03, 2024

The company received gross proceeds of approximately US$1.7 million and net proceeds,

WuXi XDC partners with IntoCell to accelerate ADC discovery and development
WuXi XDC partners with IntoCell to accelerate ADC discovery and development

By IPP Bureau - January 03, 2024

IntoCell will provide proprietary drug-linker technologies using their Ortho-Hydroxy Protected Aryl Sulfate

Ribo partners with Boehringer Ingelheim to develop new treatments for people with liver diseases
Ribo partners with Boehringer Ingelheim to develop new treatments for people with liver diseases

By IPP Bureau - January 03, 2024

Ribo's cutting edge RIBO-GalSTAR platform enables the development of RNAi therapeutics targeting disease-causing genes specifically in hepatocytes

Latest Stories

Interviews

Packaging